The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancer-Reference-Cited by-同舟云学术

The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancer

Published:2008-07-26 Issue:2 Volume:115 Page:373-380
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Bartsch Rupert, ,Mlineritsch Brigitte,Gnant Michael,Niernberger Thomas,Pluschnig Ursula,Greil Richard,Wenzel Catharina,Sevelda Paul,Thaler Josef,Rudas Margaretha,Pober Michael,Zielinski Christoph C.,Steger Guenther G.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-008-0132-0.pdf

Reference38 articles.

1. O’Shaughnessy J (2005) Extending survival with chemotherapy in metastatic breast cancer. Oncologist 10(3):20–29. doi: 10.1634/theoncologist.10-90003-20

2. Osborne CK (1998) Tamoxifen in the treatment of breast cancer. N Engl J Med 339:1609–1618. doi: 10.1056/NEJM199811263392207

3. Early Breast Cancer Trialists’ Collaborative Group (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of randomised trials. Lancet 365:1687–1717. doi: 10.1016/S0140-6736(05)66544-0

4. Paridaens R, Dirix L, Lohrisch C et al (2003) Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer. Ann Oncol 14:1391–1398. doi: 10.1093/annonc/mdg362

5. Bajetta E, Procopio G, Ferrari L et al (2002) A randomized, multicenter prospective trial assessing long-acting release octreotide pamoate plus tamoxifen as a first line therapy for advanced breast carcinoma. Cancer 94:299–304. doi: 10.1002/cncr.10239

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Participation du fulvestrant dans la crise suicidaire : à propos d’un cas;Annales Médico-psychologiques, revue psychiatrique;2018-05

2. Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer;European Journal of Cancer;2012-09

3. Recent Developments in Treatment Stratification for Metastatic Breast Cancer;Drugs;2011-11

4. Single-agent pegylated liposomal doxorubicin (PLD) in the treatment of metastatic breast cancer: results of an Austrian observational trial;BMC Cancer;2011-08-24

5. Benefits of early and prolonged fulvestrant treatment in 848 postmenopausal advanced breast cancer patients;Breast Cancer Research and Treatment;2010-10-20